Autopsy report · NCT00620100

To Determine the Objective Response Rate of 4 Cycles of Docetaxel + Anthracycline (Epirubicin or Doxorubicine) Followed by 4 Cycles of Docetaxel Single Agent

“the study was early terminated due to lack of recruitment.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 years 5 months after it had already started.
• Ran for about 7 months before it stopped.
• 2 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Sanofi

Sponsor type

Industry

Conditions

Breast Neoplasms

Interventions

Docetaxel

Participants

2

Sites

2

Countries

Austria, Poland

Trials that died the same way

• Jet Injection of 1% Buffered Lidocaine Versus Topical EMLA for Local Anesthesia Before Lumbar Puncture in Children
  “Due to low recruitment numbers, the study was terminated.” (92% match in meaning)
• Alfuzosin Versus Placebo in Acute Urinary Retention
  “The study was early terminated due to slow and difficult recruitment” (90% match in meaning)
• A Study of ANV419 Alone or in Combination With Approved Treatments in Patients With Multiple Myeloma (OMNIA-2)
  “The study was ended due to a lack of recruitment” (90% match in meaning)
• Safety, Tolerability and Efficacy of AVP-786 for the Treatment of Disinhibition
  “The study was terminated prematurely because of difficulty with recruiting.” (90% match in meaning)
• Enhancing Anti--Tetanus Vaccine Response After Autologous Stem Cell Transplantation
  “Study terminated prematurely due to poor recruitment.” (90% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.